3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
6
Recurrence
1
Immunoglobulin Light-chain Amyloidosis
1
Amyloidosis
1
Interventions
pomalidomide
1
isatuximab
1
Melphalan
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Amyloidosis
×
pomalidomide
×
Clear all
NCT05066607
2024-03-06
IsAMYP
Intergroupe Francophone du Myelome
Phase 2
Unknown
46 enrolled